High-dose Intravenous Corticosteroids for Ocular Inflammatory Diseases

Leon D. CharkoudianCenter for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA; and Emory University, Atlanta, Georgia, USA

, MD,

Gui-shuang YingCenter for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; and Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, USA

, PhD,

Siddharth S. PujariThe Massachusetts Eye Research and Surgery Institution, Cambridge, Massachusetts, USA; and LIONS NAB Eye Hospital, MIraj, Maharastra, India

, MBBS, MS (Oph), MPH,

Sapna GangaputraDepartment of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; and the Fundus Photograph Reading Center, University of Wisconsin School of Medicine, Madison, Wisconsin, USA

, MBBS, MPH,

Jennifer E. ThorneDepartment of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; and Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA

, MD, PhD,

C. Stephen FosterThe Massachusetts Eye Research and Surgery Institution, Cambridge, Massachusetts, USA; and Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA

, MD,

Douglas A. JabsDepartment of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA; and Departments of Ophthalmology and Medicine, Mount Sinai School of Medicine, New York, New York, USA

, MD, MBA,

Grace A. Levy-ClarkeSt. Luke’s Cataract and Laser Institute, Tarpon Springs, Florida; and Laboratory of Immunology, National Eye Institute, Bethesda, Maryland, USA

, MD,

Robert B. NussenblattLaboratory of Immunology, National Eye Institute, Bethesda, Maryland, USA

, MD, MPH,

James T. RosenbaumDepartments of Ophthalmology and Medicine, Oregon Health & Science University, Portland, Oregon, USA

, MD,

Eric B. SuhlerDepartment of Ophthalmology, Oregon Health & Science University, Portland, Oregon, USA; and Portland Veterans’ Affairs Medical Center, Portland, Oregon, USA

, MD, MPH &

John H. KempenCenter for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; and Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, USACorrespondence[email protected]

, MD, PhD show all

High-dose Intravenous Corticosteroids for Ocular Inflammatory Diseases

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

High-dose Intravenous Corticosteroids for Ocular Inflammatory Diseases

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date